Remicade's approval for ulcerative colitis raises questions about new high-tech versus older approaches

Remicade's approval for ulcerative colitis raises questions about new high-tech versus older approaches.

Over 500,000 Americans try various drugs for ulcerative colitis. About 85% of patients with severe disease end up with a colectomy when the drugs don't work.

But this is changing.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote